You are reading:
Healthy Participants
|
The Immune Response Study
Healthy Participants
The Immune Response Study
Start date
Jun 25th, 30th, Jul 01st
Renumeration
$9,465
4 nights, 7-12 appointments
Help Test a New Treatment for Inflammatory Bowel Disease (IBD)
This clinical study is evaluating a new antibody treatment for Inflammatory Bowel Disease (IBD), a condition that causes abdominal pain and diarrhoea. The primary goal is to assess the safety and tolerability of the treatment in healthy adult participants.